Cargando…

Lipoprotein-Associated Phospholipase A2 (Lp-PLA(2)): A Novel and Promising Biomarker for Cardiovascular Risks Assessment

Atherosclerosis and its manifestations namely cardiovascular diseases (CVD) are still the leading cause of morbidity and mortality worldwide. Although intensified interventions have been applied, the residual cardiovascular (CV) risks are still very high. Lipoprotein-associated phospholipase A2 (Lp-...

Descripción completa

Detalles Bibliográficos
Autores principales:	Cai, Anping, Zheng, Dongdan, Qiu, Ruofeng, Mai, Weiyi, Zhou, Yingling
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	IOS Press 2013
Materias:	Other
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3810239/ https://www.ncbi.nlm.nih.gov/pubmed/23478277 http://dx.doi.org/10.3233/DMA-130976

Ejemplares similares

Effects and potential mechanism of atorvastatin treatment on Lp-PLA2 in rats with dyslipidemia
por: Zheng, Dongdan, et al.
Publicado: (2017)

Baseline elevated Lp-PLA2 is associated with increased risk for re-stenosis after stent placement
por: Zheng, Dongdan, et al.
Publicado: (2014)

Lipoprotein(a): A Promising Marker for Residual Cardiovascular Risk Assessment
por: Cai, Anping, et al.
Publicado: (2013)

STABILITY and SOLID-TIMI 52: Lipoprotein associated phospholipase A(2) (Lp-PLA(2)) as a biomarker or risk factor for cardiovascular diseases
por: Hassan, Mohamed
Publicado: (2015)

Antioxidant and inflammatory aspects of lipoprotein-associated phospholipase A(2 )(Lp-PLA(2 )): a review
por: Silva, Isis T, et al.
Publicado: (2011)

Lipoprotein-associated phospholipase A2 (Lp-PLA2) – possible diagnostic and risk biomarker in chronic ischaemic heart disease
por: Diaconu, Adriana, et al.
Publicado: (2020)

Distribution of Paraoxonase-1 (PON-1) and Lipoprotein Phospholipase A2 (Lp-PLA2) across Lipoprotein Subclasses in Subjects with Type 2 Diabetes
por: Passaro, Angelina, et al.
Publicado: (2018)

Atorvastatin Treatment of Rats with Ischemia-Reperfusion Injury Improves Adipose-Derived Mesenchymal Stem Cell Migration and Survival via the SDF-1α/CXCR-4 Axis
por: Cai, Anping, et al.
Publicado: (2013)

SDF-1α upregulation by atorvastatin in rats with acute myocardial infarction via nitric oxide production confers anti-inflammatory and anti-apoptotic effects
por: Qiu, Ruofeng, et al.
Publicado: (2012)

Increased serum level of Lp-PLA2 is independently associated with the severity of coronary artery diseases: a cross-sectional study of Chinese population
por: Cai, Anping, et al.
Publicado: (2015)

The Utility of the Lipoprotein-Associated Phospholipase A(2) (Lp-PLA(2)) Assay in Detecting Abnormalities in Lipid Metabolism and Cardiovascular Risk in an HIV-Infected South African Cohort
por: Mayne, Elizabeth S., et al.
Publicado: (2019)

Relationship of lipoprotein-associated phospholipase A2(Lp-PLA2) and periprocedural myocardial injury in patients undergoing elective percutaneous coronary intervention
por: Yin, Yun-jie, et al.
Publicado: (2020)

Lp-PLA(2) Inhibitors for the Reduction of Cardiovascular Events
por: Steen, Dylan L., et al.
Publicado: (2013)

Influence of obesity and cardiometabolic makers on lipoprotein-associated phospholipase A(2) (Lp-PLA(2)) activity in adolescents: the healthy young cross-sectional study
por: da Silva, Isis T, et al.
Publicado: (2013)

Investigation of the Brain Biodistribution of the Lipoprotein-Associated Phospholipase A(2) (Lp-PLA(2)) Inhibitor [(18)F]GSK2647544 in Healthy Male Subjects
por: Huiban, Mickael, et al.
Publicado: (2016)

A Review of Novel Cardiac Biomarkers in Acute or Chronic Cardiovascular Diseases: The Role of Soluble ST2 (sST2), Lipoprotein-Associated Phospholipase A2 (Lp-PLA2), Myeloperoxidase (MPO), and Procalcitonin (PCT)
por: Li, Junpei, et al.
Publicado: (2021)

Lipoprotein-associated phospholipase A(2 )(Lp-PLA(2)) activity, platelet-activating factor acetylhydrolase (PAF-AH) in leukocytes and body composition in healthy adults
por: Detopoulou, Paraskevi, et al.
Publicado: (2009)

Resveratrol Treatment Is Associated with Lipid Regulation and Inhibition of Lipoprotein-Associated Phospholipase A2 (Lp-PLA2) in Rabbits Fed a High-Fat Diet
por: Xu, Lei, et al.
Publicado: (2020)

Baseline LDL-C and Lp(a) Elevations Portend a High Risk of Coronary Revascularization in Patients after Stent Placement
por: Cai, Anping, et al.
Publicado: (2013)

Atorvastatin protects endothelium by decreasing asymmetric dimethylarginine in dyslipidemia rats
por: Zheng, Dongdan, et al.
Publicado: (2015)

Lp-PLA2 Inhibition—The Atherosclerosis Panacea?
por: Karakas, Mahir, et al.
Publicado: (2010)

Association of Carotid Plaque and Serum Lipoprotein-Associated Phospholipase A2 (LP-PLA2) with Postoperative Delirium in Geriatric Patients Undergoing Hip Replacement: A Prospective Cohort Study
por: Wan, Tiantian, et al.
Publicado: (2020)

Lp-PLA(2), a new biomarker of vascular disorders in metabolic diseases
por: De Stefano, Alessandro, et al.
Publicado: (2019)

Increased Lipoprotein-associated phospholipase A2 activity portends an increased risk of resistant hypertension
por: Li, Zhiming, et al.
Publicado: (2016)

Lp-PLA2 levels in HIV-infected patients
por: Díaz-Pollán, Beatriz, et al.
Publicado: (2014)

Genetic invalidation of Lp-PLA(2) as a therapeutic target: Large-scale study of five functional Lp-PLA(2)-lowering alleles
por: Gregson, John M, et al.
Publicado: (2016)

Association Lp-PLA2 Gene Polymorphisms with Coronary Heart Disease
por: Ma, Sha, et al.
Publicado: (2022)

Identification of Inflammation-Related Biomarker Lp-PLA2 for Patients With COPD by Comprehensive Analysis
por: Deng, Mingming, et al.
Publicado: (2021)

Oxidized phospholipids and lipoprotein-associated phospholipase A(2) as important determinants of Lp(a) functionality and pathophysiological role
por: Tselepis, Alexandros D.
Publicado: (2018)

On the present and future role of Lp-PLA(2) in atherosclerosis-related cardiovascular risk prediction and management
por: Fras, Zlatko, et al.
Publicado: (2020)

Lp-PLA2 as a biomarker and its possible associations with SARS-CoV-2 infection
por: Dua, Pamila, et al.
Publicado: (2022)

The Relationship between Intracarotid Plaque Neovascularization and Lp (a) and Lp-PLA2 in Elderly Patients with Carotid Plaque Stenosis
por: Sun, Chang, et al.
Publicado: (2022)

Lipoprotein associated phospholipase A(2): role in atherosclerosis and utility as a biomarker for cardiovascular risk
por: Colley, Kenneth J., et al.
Publicado: (2011)

Differential expression of Lp-PLA2 in obesity and type 2 diabetes and the influence of lipids
por: Jackisch, Laura, et al.
Publicado: (2018)

Association between Lp-PLA2 and coronary heart disease in Chinese patients
por: Yang, Li, et al.
Publicado: (2017)

The changes of Lp-PLA2 in patients with gestational diabetes and its clinical significance
por: Wang, Guo-Hua, et al.
Publicado: (2021)

Homocysteine and Lp-PLA2 levels: Diagnostic value in coronary heart disease
por: Wu, Linlin, et al.
Publicado: (2023)

Prehypertension-Associated Elevation in Circulating Lysophosphatidlycholines, Lp-PLA(2) Activity, and Oxidative Stress
por: Kim, Minjoo, et al.
Publicado: (2014)

Sequencing of Lp-PLA2-encoding PLA2G7 gene in 2000 Europeans reveals several rare loss-of-function mutations
por: Song, K, et al.
Publicado: (2012)

Lipoprotein-Associated Phospholipase A(2), Vascular Inflammation and Cardiovascular Risk Prediction
por: Sudhir, Krishnankutty
Publicado: (2006)

Cannot write session to /tmp/vufind_sessions/sess_vlt6llfj8ljuhali99jfitoilo